In preclinical mouse melanoma models, GCN2-deficient T cells demonstrated similar antitumor effect to wild-type T cells against B16 melanoma cell line, highlighting that immune regulation by GCN2 is presumably context-dependent (38). Here, EIF2AK4 is linked to melanoma.